Page 102 - Orange Book Cumulative Supplement 10 October 2012
P. 102

RX DRUG PRODUCT LIST   -   CUMULATIVE SUPPLEMENT  10  -  October 2012        1-92


                     CAPSULE, DELAYED RELEASE; ORAL
                       ULTRESA
                     +    APTALIS PHARMA US    46,000USP UNITS;23,000USP        N022222 003  Mar 01, 2012 Mar  NEWA
                                               UNITS;46,000USP UNITS
                       ZENPEP
                          APTALIS PHARMA US    16,000USP UNITS;3,000USP         N022210 005  Jun 15, 2011 Apr  NEWA
                                               UNITS;10,000USP UNITS
                                               109,000USP UNITS;20,000USP       N022210 004  Aug 27, 2009 Apr  CRLD
                                               UNITS;68,000USP UNITS
                     +                         136,000USP UNITS;25,000USP       N022210 006  Jul 13, 2011 Apr  NEWA
                                               UNITS;85,000USP UNITS
                     TABLET; ORAL
                       VIOKACE
                          APTALIS PHARMA US    39,150USP UNITS;10,440USP        N022542 001  Mar 01, 2012 Mar  NEWA
                                               UNITS;39,150USP UNITS
                     +                         78,300USP UNITS;20,880USP        N022542 002  Mar 01, 2012 Mar  NEWA
                                               UNITS;78,300USP UNITS
                   PANTOPRAZOLE SODIUM
                     INJECTABLE; IV (INFUSION)
           >A>         PANTOPRAZOLE SODIUM
           >A>  AP       AKORN INC             EQ 40MG BASE/VIAL                A079197 001  Nov 08, 2012 Oct  NEWA
                       PROTONIX IV
           >D>       +   WYETH PHARMS INC      EQ 40MG BASE/VIAL                N020988 001  Mar 22, 2001 Oct  CFTG
           >A>  AP   +                         EQ 40MG BASE/VIAL                N020988 001  Mar 22, 2001 Oct  CFTG
                     TABLET, DELAYED RELEASE; ORAL
                       PANTOPRAZOLE SODIUM
                AB       APOTEX INC            EQ 20MG BASE                     A090807 001  May 02, 2012 Apr  NEWA
                AB                             EQ 40MG BASE                     A090807 002  May 02, 2012 Apr  NEWA
                AB       AUROBINDO PHARMA LTD  EQ 20MG BASE                     A202038 001  Sep 28, 2012 Sep  NEWA
                AB                             EQ 40MG BASE                     A202038 002  Sep 28, 2012 Sep  NEWA
                AB       MACLEODS PHARMS LTD   EQ 20MG BASE                     A200821 001  Feb 16, 2012 Jan  NEWA
                AB                             EQ 40MG BASE                     A200821 002  Feb 16, 2012 Jan  NEWA
                AB       MYLAN PHARMS INC      EQ 20MG BASE                     A090970 001  Jan 19, 2011 Sep  CAHN
                AB                             EQ 40MG BASE                     A090970 002  Jan 19, 2011 Sep  CAHN
                AB       RANBAXY LABS LTD      EQ 20MG BASE                     A200794 001  May 02, 2012 Apr  NEWA
                AB                             EQ 40MG BASE                     A200794 002  May 02, 2012 Apr  NEWA

                   PAROXETINE HYDROCHLORIDE
                     TABLET; ORAL
                       PAROXETINE HYDROCHLORIDE
                AB       ACTAVIS ELIZABETH     EQ 10MG BASE                     A076968 001  Jun 21, 2010 Feb  CMFD
                AB                             EQ 20MG BASE                     A076968 002  Jun 21, 2010 Feb  CMFD
                AB                             EQ 30MG BASE                     A076968 003  Jun 21, 2010 Feb  CMFD
                AB                             EQ 40MG BASE                     A076968 004  Jun 21, 2010 Feb  CMFD
                AB       MYLAN PHARMS INC      EQ 10MG BASE                     A075716 001  Mar 08, 2004 Sep  CAHN
                AB                             EQ 20MG BASE                     A075716 002  Mar 08, 2004 Sep  CAHN
                AB                             EQ 30MG BASE                     A075716 003  Mar 08, 2004 Sep  CAHN
                AB                             EQ 40MG BASE                     A075716 004  Mar 08, 2004 Sep  CAHN
                AB       PROSAM LABS           EQ 10MG BASE                     A076968 001  Jun 21, 2010 Sep  CAHN
                AB                             EQ 20MG BASE                     A076968 002  Jun 21, 2010 Sep  CAHN
                AB                             EQ 30MG BASE                     A076968 003  Jun 21, 2010 Sep  CAHN
                AB                             EQ 40MG BASE                     A076968 004  Jun 21, 2010 Sep  CAHN

                   PEGAPTANIB SODIUM
                     INJECTABLE; INTRAVITREAL
                       MACUGEN
                     +   VALEANT PHARMS LLC    EQ 0.3MG ACID/0.09ML             N021756 001  Dec 17, 2004 May  CAHN
   97   98   99   100   101   102   103   104   105   106   107